Standout Papers

Surfing the p53 network 1979 2026 1994 2010 5.4k
  1. Surfing the p53 network (2000)
    Bert Vogelstein, David P. Lane et al. Nature
  2. T antigen is bound to a host protein in SY40-transformed cells (1979)
    David P. Lane, L.V. Crawford Nature
  3. p53 in health and disease (2007)
    Karen H. Vousden, David P. Lane Nature Reviews Molecular Cell Biology
  4. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms (1990)
    Peter A. Hall, David A. Levison et al. The Journal of Pathology
  5. Increased expression of mutant forms of p53 oncogene in primary lung cancer (1990)
    Richard Iggo, Jiří Bártek et al. The Lancet
  6. p53 mutations in colorectal cancer. (1990)
    Nanda R. Rodrigues, Andrew Rowan et al. Proceedings of the National Academy of Sciences
  7. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. (1990)
    Julian Gannon, R Greaves et al. The EMBO Journal
  8. Regulation of the specific DNA binding function of p53 (1992)
    Ted R. Hupp, David W. Meek et al. Cell
  9. Awakening guardian angels: drugging the p53 pathway (2009)
    Christopher J. Brown, Sonia Laı́n et al. Nature reviews. Cancer
  10. p53: oncogene or anti-oncogene? (1990)
    David P. Lane, Samuel Benchimol Genes & Development
  11. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA) structural conservation and the detection of a nucleolar form (1990)
    Naushin Waseem, David P. Lane Journal of Cell Science
  12. p53 isoforms can regulate p53 transcriptional activity (2005)
    Jean‐Christophe Bourdon, Kenneth Fernandes et al. Genes & Development
  13. High levels of p53 protein in UV-irradiated normal human skin. (1993)
    R. Dover, David P. Lane et al. PubMed
  14. Drugging the p53 pathway: understanding the route to clinical efficacy (2014)
    Kian Hoe Khoo, Chandra Verma et al. Nature Reviews Drug Discovery
  15. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. (1990)
    Jiří Bártek, Richard Iggo et al. PubMed
  16. SUMO-1 modification activates the transcriptional response of p53 (1999)
    Manuel S. Rodríguez, Joana Desterro et al. The EMBO Journal
  17. Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents. (1994)
    Ahuva Nissim, H.R. Hoogenboom et al. The EMBO Journal
  18. Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others (2017)
    Kanaga Sabapathy, David P. Lane Nature Reviews Clinical Oncology

Immediate Impact

19 by Nobel laureates 92 from Science/Nature 182 standout
Sub-graph 1 of 13

Citing Papers

Cancer Genome Landscapes
2013 StandoutScience
Hallmarks of Cancer: The Next Generation
2011 Standout
9 intermediate papers

Works of David P. Lane being referenced

Small peptides activate the latent sequence-specific DNA binding function of p53
1995
Allosteric activation of latent p53 tetramers
1994
and 15 more

Author Peers

Author Last Decade Papers Cites
David P. Lane 37043 31996 6900 8635 606 57.0k
Wafik S. El‐Deiry 32596 23024 4645 9235 569 46.2k
Moshe Oren 34533 28528 7097 9746 323 48.3k
Charles J. Sherr 38985 30272 3307 6856 270 57.5k
Scott W. Lowe 49438 22670 3934 16688 324 68.3k
Karen H. Vousden 34167 24148 4687 12175 239 48.4k
Curtis C. Harris 40543 21985 3735 24469 571 65.7k
Ronald A. DePinho 55409 22760 3136 13587 416 84.9k
Carlos Cordon‐Cardo 40955 22560 2445 12688 563 67.3k
Roderick T. Bronson 45554 22954 2609 11505 543 76.8k
Tyler Jacks 58358 33760 6183 26145 336 86.1k

All Works

Loading papers...

Rankless by CCL
2026